Adherence to the Mediterranean Diet, emotional well-being and lifestyle patterns in Spain: A cross-sectional study
OBJECTIVES: This study examined whether adherence to the Mediterranean Diet (MedDiet) is associated with emotional states, lifestyle behaviors, and subjective well-being in Spanish adults.
METHODS: We conducted a cross-sectional survey in Spain between July and October 2023 of 2751 adults across 14 major cities. Participants completed digital questionnaires on weekly frequency of six basic emotions, anxiety, life satisfaction, happiness, and health behaviors. MedDiet adherence was assessed via a weighted 15-item score and categorized into tertiles. Associations were examined using multivariate, covariate-adjusted models.
RESULTS: Higher MedDiet adherence was significantly associated with greater joy and surprise, and lower anger, disgust, and sadness (all p < 0.05). Participants in the highest tertile reported more frequent sport (p < 0.01), cooking, and social activities, along with higher life satisfaction and happiness (p < 0.01). Beer and wine showed distinct patterns: beer was linked to greater anger, whereas wine related to more sport and reduced anxiety.
CONCLUSIONS: MedDiet adherence reflects a lifestyle characterized by emotional balance and well-being, with distinct psychosocial patterns for wine and beer.
Additional Info
-
Authors
Buhler K. M.; Calleja-Conde J.; Bressa C.; Gomez-Gallego F.; Albert J.; Perez-Wiesner M.; Lopez-Moreno J. A. -
Issue
Periodical: Prev Med Rep - Volume: 61 - Edition: 20260106 -
Published Date
06 january 2026
Related items
- Exploring the Associations Between Mediterranean Diet Adherence and Autoinflammation-Associated Skin Diseases
- Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol-free and low-alcohol products in higher risk groups
- The illusion of healthy drinking: Methodological bias and selective reporting of effects shape evidence on alcohol and cardiovascular health
- A review of the relationship between dimensions of alcohol consumption and the burden of disease: 2026 update including Mendelian randomisation studies
- Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial